Travere Therapeutics Option Alert: Feb 20 $37.5 Calls at the Bid: 2500 vs 1500 OI

Travere Therapeutics Option Alert: Feb 20 $37.5 Calls at the Bid: 2500 @ $4.1 vs 1500 OI; Ref=$35.37

Travere Therapeutics Azioni (NASDAQ: TVTX)

Travere Therapeutics (NASDAQ:TVTX) Azioni, Quote.MetaTitle.unusual-options

Travere Therapeutics

Travere Therapeutics, Inc. - Common Stock

Panoramica

Notizie

Utili

Opzioni

Guidance

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Comments

Travere Therapeutics Opzioni Inusuali

Attività insolita sulle opzioni per Travere Therapeutics Inc (NASDAQ:TVTX)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO